CVS Health Co. (NYSE:CVS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

CVS Health Co. (NYSE:CVS) has received an average rating of “Moderate Buy” from the twenty brokerages that are currently covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $73.00.

Several equities analysts have recently commented on the company. Evercore ISI upped their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. Barclays reduced their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Mizuho dropped their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. UBS Group raised their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st.

Institutional Trading of CVS Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the 3rd quarter worth $25,000. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the third quarter valued at about $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA raised its holdings in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health during the 3rd quarter worth approximately $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

NYSE:CVS opened at $55.81 on Tuesday. CVS Health has a 12-month low of $52.77 and a 12-month high of $83.25. The firm has a market capitalization of $70.23 billion, a price-to-earnings ratio of 14.16, a P/E/G ratio of 0.88 and a beta of 0.55. The stock’s 50 day moving average price is $59.56 and its two-hundred day moving average price is $59.06. The company has a quick ratio of 0.66, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter last year, the firm posted $2.21 EPS. The company’s quarterly revenue was up 6.3% on a year-over-year basis. On average, analysts anticipate that CVS Health will post 5.63 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.77%. CVS Health’s payout ratio is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.